Six red flags for suspect work

C. Glenn Begley ()
Additional contact information
C. Glenn Begley: C. Glenn Begley is senior vice-president at TetraLogic Pharmaceuticals, Malvern, Pennsylvania, USA.

Nature, 2013, vol. 497, issue 7450, 433-434

Abstract: C. Glenn Begley explains how to recognize the preclinical papers in which the data won't stand up.

Date: 2013
References: Add references at CitEc
Citations: View citations in EconPapers (5)

Downloads: (external link)
https://www.nature.com/articles/497433a Abstract (text/html)
Access to the full text of the articles in this series is restricted.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:nat:nature:v:497:y:2013:i:7450:d:10.1038_497433a

Ordering information: This journal article can be ordered from
https://www.nature.com/

DOI: 10.1038/497433a

Access Statistics for this article

Nature is currently edited by Magdalena Skipper

More articles in Nature from Nature
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().